Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3502Neoplasms 2744Prostatic Neoplasms 1585Colorectal Neoplasms 1248Lung Neoplasms 1190Motor Activity 768Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 561Carcinoma, Hepatocellular 561Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 439Ovarian Neoplasms 401Anxiety Disorders 401Pain 377Esophageal Neoplasms 347Polycystic Ovary Syndrome 341Neoplasm Metastasis 340Fatigue 325Urinary Bladder Neoplasms 315Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 299Depression 286Multiple Myeloma 283Endometrial Neoplasms 264Lymphoma 258Hematologic Neoplasms 251

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER × Safety Issues × Clear all
NCT06509490 2024-07-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
9 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡